PMDD is also associated with mood swings, depression, and anxiety, but its symptoms are more severe and can last for up to two weeks at a time. The lifetime toll of PMDD is comparable to that for people with major depressive disorder.
Previous studies compared fluctuations in ovarian hormones between women with PMDD and healthy women interestingly found no substantial differences, suggesting that dysregulated hormones in the periphery are not the underlying cause of the disorder.
Advertisement
An alternative idea is that the brain’s response to normal endogenous hormonal changes differs in patients with PMDD, although how that happens remains unclear.
In the current study, researchers examined 30 patients with PMDD and 29 unaffected control women throughout two menstrual cycles. They used positron emission tomography (PET) imaging to visualize the availability of the serotonin transporter protein in the brain throughout the cycle, reflecting short-term changes in its expression.
They found a significant increase of serotonin transporter from periovulatory to premenstrual phase in patients with PMDD – an 18% change in the midbrain, a brain region with the richest serotonin transporter expression. This increase was associated with the severity of depressed mood premenstrually.
Unexpectedly, they also found a decrease in midbrain serotonin transporter density in healthy women, which could point to a protective mechanism of the healthy female brain during a changing hormonal environment.
Does Serotonin Reuptake Inhibitors help with Premenstrual Dysphoric Disorder (PMDD)?
Typically, it is assumed that serotonin transporter density is an individual trait, with only an approximately 10% change over a decade as the human brain ages, rather than a state that changes within shorter periods. However, studies in patients with seasonal affective disorder (SAD) show seasonal changes in serotonin transporter.
Although the reports of serotonin transporter availability in depression have been mixed, this may be due to the heterogeneity of that disease. In more homogenous types of affective disorders, such as PMDD or SAD, relatively rapid dynamics of serotonin transporter availability seem to play an important role.
This technically demanding study identifies a new potential mechanism contributing to negative premenstrual mood states in some women. It also supports the use of selective serotonin reuptake inhibitors (a type of antidepressant) to treat premenstrual dysphoric mood.
These findings provide evidence that individuals with PMDD experience short-term changes in serotonin transporter density throughout the menstrual cycle, which suggests that patients might benefit from taking SSRIs at specific times during the cycle to best target these changes.
Source: Eurekalert
Source link
#Serotonin #Brain #MenstrualRelated #Mood #Disorders
